Nonsense mediated decay factor UPF3B is associated with cMyBP-C haploinsufficiency in hypertrophic cardiomyopathy

Valentin Burkart1, Kathrin Kowalski1, Alina Disch1

  • 1Institute for Molecular and Cell Physiology, Hannover Medical School, Hannover, Germany.

Insights

Hypertrophic cardiomyopathy (HCM) is linked to myosin binding protein C (cMyBP-C) gene mutations. UPF3B-dependent nonsense-mediated decay (NMD) at the Z-disc explains cMyBP-C haploinsufficiency in HCM patients.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Biology
  • Cell Biology

Background:

  • Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease, often caused by mutations in the MYBPC3 gene.
  • Many MYBPC3 mutations result in premature termination codons (PTCs), leading to reduced functional myosin binding protein C (cMyBP-C) and haploinsufficiency, a likely driver of HCM.
  • Distinguishing HCM-specific mechanisms from general hypertrophy is crucial, necessitating controls like aortic stenosis (AS).

Purpose of the Study:

  • To investigate the molecular mechanisms underlying cMyBP-C haploinsufficiency in HCM patients with MYBPC3 truncation mutations.
  • To determine if haploinsufficiency originates at the transcriptional, mRNA, or protein level.
  • To identify specific cellular pathways involved in HCM pathogenesis related to MYBPC3 mutations.

Main Methods:

  • Analysis of cardiac tissue from HCM patients with MYBPC3 truncation mutations (MYBPC3trunc) and AS patients, compared to donor controls.
  • Assessment of transcriptional activity, mRNA, and protein expression levels.
  • RNA-sequencing and Gene Set Enrichment Analysis (GSEA) to identify differentially expressed genes and pathways, focusing on nonsense-mediated decay (NMD) components.
  • Immunolocalization studies to determine the subcellular localization of NMD factors (UPF1, UPF2, UPF3B) within sarcomeres.

Main Results:

  • cMyBP-C haploinsufficiency in MYBPC3trunc HCM patients begins at the mRNA level, despite increased transcriptional activity due to hypertrophy.
  • GSEA revealed upregulation of NMD pathway components in MYBPC3trunc patients.
  • Up-frameshift protein UPF3B, an NMD regulator, was specifically upregulated in MYBPC3trunc patients but not in AS patients.
  • UPF3B, unlike UPF1 and UPF2, was localized to sarcomeric Z-discs, the site of sarcomeric protein translation.

Conclusions:

  • UPF3B-dependent nonsense-mediated decay (NMD) is a key mechanism establishing cMyBP-C haploinsufficiency in HCM.
  • This NMD process occurs during the initial translation round at the sarcomeric Z-disc.
  • These findings provide novel insights into the molecular pathogenesis of HCM driven by MYBPC3 mutations.

Related Concept Videos

Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.7K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
142.1K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
14
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.7K